Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
Record: https://fundinglandscape.com/opportunity/cmi5cw5pz0001jy04hji5h6pa · Official notice: https://www.grants.gov/search-results-detail/360873
Open. Deadline Jun 20, 2029. Notice RFA-AI-27-018. Last seen at source (current status: https://fundinglandscape.com/opportunity/cmi5cw5pz0001jy04hji5h6pa)
Deadline: Jun 20, 2029. Add to calendar: https://fundinglandscape.com/opportunity/cmi5cw5pz0001jy04hji5h6pa/deadline.ics (Google Calendar: https://fundinglandscape.com/opportunity/cmi5cw5pz0001jy04hji5h6pa/calendar/google)
Posted: October 6, 2026
Issuer: National Institutes of Health
Submit through the official notice: https://www.grants.gov/search-results-detail/360873
Funding Landscape's record of a notice published on Grants.gov.
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for implementation science to end the HIV epidemic.
- Status
- Open
- Closes
- Jun 20, 2029942 days left
- Posted
- October 6, 2026
- Eligibility
- Special districts, County governments, NonprofitsAll 14 applicant types and requirements
- Issuer
- National Institutes of Health
- Notice number
- RFA-AI-27-018
Funding Landscape alerts
Email me listings like thisClose email options
Email me listings like this
National Institutes of Health
You'll get new grants from National Institutes of Health.
Weekly emails when there are new matches. You may also receive an initial email. Stop any time.
Description
Read the full description
Projects will leverage research-community collaborations to bring evidence-based advances in HIV prevention, diagnosis, treatment, and cluster outbreak response to communities disproportionately impacted by HIV. The goals of these projects will be to: (1) Develop strategies to end HIV by integrating innovations across disciplines such as epidemiology, data science, public health, medicine, social services, implementation science, and community engagement, and (2) Deploy, test, and evaluate new or existing strategies at multiple geographic locations or settings. While deployment of these strategies will occur at the local scale, through partnerships with, local, state, and federal public health partners, the overall program will advance generalized knowledge that informs larger scale efforts to end HIV. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Requirements
- Applicant types
- Special district governments, Others (see text field entitled "Additional Information on Eligibility" for clarification), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal governments (Federally recognized), For profit organizations other than small businesses
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About Funding Landscape
Open grants and government contracts.
Search open grants and contracts on Funding Landscape
Find similar listings
Similar open listings
- Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)Same funderOpenNational Institutes of HealthCloses Oct 2028Up to $200K
- Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jul 2029Up to $450K
- Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Oct 2027
- Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2027Up to $3.5M